Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

ultra long-acting GLP-1 implant produced sham-implant adjusted liver fat reduction of 82% in an obese mouse model from a ...

Meanwhile, semaglutide remains on the shortages list, but Novo Nordisk hopes it won’t be for long. The company last week noted that the last remaining dose in short supply, the lowest dose of ...

While semaglutide remains on the shortage list, Novo Nordisk noted last week that the last remaining dose in short supply -- the lowest dose of Wegovy -- is now listed as available, CNN reported.

The topline results from the ESSENCE trial of semaglutide showed that a once-weekly 2.4mg dose of the drug was better than placebo at resolving MASH and improving liver fibrosis, meeting its ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Semaglutide, the active ingredient doing all the work ... but it’s something to consider if you’re not yet certain about the ...

In currently pre-published work, gradual dose-tapering of the GLP-1R agonist semaglutide following full-dosage cessation has been tentatively suggested to help maintain reductions in body weight for ...